FEBUOXATE 80 is a prescription-strength urate-lowering medication formulated with Febuxostat 80 mg, primarily used for the effective long-term management of gout and chronic hyperuricemia. Gout is a painful metabolic disorder caused by persistently high levels of uric acid in the blood, leading to the formation of urate crystals in joints and surrounding tissues. These crystals trigger severe inflammation, intense pain, swelling, redness, and reduced joint mobility.
Febuxostat, the active ingredient in FEBUOXATE 80, belongs to the class of xanthine oxidase inhibitors. It works by blocking the enzyme xanthine oxidase, which plays a key role in uric acid synthesis. By reducing uric acid production at its source, FEBUOXATE 80 helps maintain serum uric acid levels within the recommended range, thereby preventing gout flare-ups and long-term joint damage.
Manufactured under strict quality control standards, FEBUOXATE 80 offers consistent efficacy, safety, and reliability. It is generally prescribed for patients who require stronger uric acid control, especially those who do not achieve target uric acid levels with lower doses. With regular use under medical supervision, FEBUOXATE 80 supports better joint health, mobility, and overall quality of life.
Uses
FEBUOXATE 80 is indicated for the treatment and prevention of conditions associated with elevated uric acid levels. Its primary uses include:
Chronic Gout Management – Helps control and prevent recurrent gout attacks by maintaining low uric acid levels.
Severe Hyperuricemia – Prescribed when lower doses of urate-lowering therapy fail to achieve adequate control.
Prevention of Uric Acid Crystal Deposition – Reduces the formation and accumulation of urate crystals in joints and soft tissues.
Reduction of Tophaceous Gout Risk – Helps prevent the development of tophi caused by prolonged uric acid deposition.
Kidney Protection – Lowers the risk of uric acid-related kidney stones and renal complications.
FEBUOXATE 80 is not intended for the treatment of acute gout pain but is used as a long-term preventive therapy to control uric acid levels and minimize future flare-ups.
Benefits
Regular use of FEBUOXATE 80 provides significant clinical benefits for patients with gout and high uric acid levels:
Powerful Uric Acid Reduction – The higher 80 mg strength provides enhanced inhibition of uric acid synthesis.
Prevents Gout Attacks – Maintains serum uric acid below target levels, reducing the frequency of painful gout flare-ups.
Protects Joints from Damage – Prevents crystal-induced inflammation that leads to joint erosion and deformity.
Improves Mobility and Comfort – Gradual reduction in pain, stiffness, and swelling improves daily functioning.
Effective in Resistant Cases – Suitable for patients who do not respond adequately to lower-dose therapy.Supports Long-Term Disease Control – Helps manage gout as a chronic condition with sustained benefits.
By targeting the root cause of gout, FEBUOXATE 80 offers comprehensive disease control rather than temporary symptom relief.
Dosage
The dosage of FEBUOXATE 80 must be decided by a healthcare professional based on uric acid levels, disease severity, and individual response to therapy. General dosage guidelines include:
Recommended Dose: One tablet of Febuxostat 80 mg once daily
Administration: Can be taken with or without food, preferably at the same time every day
Dose Escalation: Usually prescribed when Febuxostat 40 mg does not adequately control uric acid levels
Treatment Duration: Long-term or lifelong therapy may be required in chronic gout patients
During the early phase of treatment, gout flare-ups may temporarily increase due to mobilization of urate crystals. Doctors may prescribe additional medicines to manage this phase. Patients should not discontinue FEBUOXATE 80 without medical advice, even if symptoms improve.
Side Effects
FEBUOXATE 80 is generally well tolerated, but some patients may experience side effects, particularly during the initial stages of treatment.
Common side effects include:
Nausea
Headache
Dizziness
Diarrhea
Mild skin rash
Less common but serious side effects may include:
Abnormal liver function tests
Severe allergic reactions
Cardiovascular symptoms such as chest discomfort (rare)
Routine monitoring of liver function is recommended during therapy. Any severe or persistent side effects should be reported to a healthcare professional immediately.
Precautions and Warning
Before using FEBUOXATE 80, patients should consider the following precautions and warnings:
Not for Acute Gout Relief: Should not be used to treat sudden gout pain attacks.
Liver Disease: Use cautiously in patients with liver impairment; regular monitoring is advised.
Heart Conditions: Patients with a history of cardiovascular disease should inform their doctor before starting therapy.
Pregnancy and Breastfeeding: Safety has not been established; use only if clearly prescribed.
Drug Interactions: Avoid use with azathioprine or mercaptopurine unless strictly supervised.
Alcohol Consumption: Excessive alcohol intake may increase uric acid levels and reduce treatment effectiveness.
Strict adherence to medical guidance ensures the safe and effective use of FEBUOXATE 80.
Conclusion
FEBUOXATE 80 Febuxostat 80 mg Tablet is a potent and reliable urate-lowering therapy designed for patients with gout and severe hyperuricemia requiring stronger control. By inhibiting xanthine oxidase and reducing uric acid synthesis, it addresses the root cause of gout, helping prevent painful flare-ups and long-term joint damage.
With its once-daily dosing, proven efficacy, and suitability for long-term use, FEBUOXATE 80 is widely trusted by healthcare professionals. When taken consistently under medical supervision, it significantly improves joint health, mobility, and overall quality of life.
